
Zhuhai Rundu Pharmaceutical Co., Ltd. — Investor Relations & Filings
Zhuhai Rundu Pharmaceutical Co., Ltd. is an integrated enterprise focused on the research, development, production, and commercialization of chemical drug substances, pharmaceutical intermediates, and finished formulations. The company specializes in therapeutic areas including cardiovascular health, digestive system treatments, and anti-infective medications. Its technical expertise lies in the development of sustained-release and controlled-release delivery systems. Key products include Irbesartan and Hydrochlorothiazide tablets, Rabeprazole Sodium enteric-coated tablets, and various active pharmaceutical ingredients (APIs). By maintaining a complete industrial chain from intermediates to final dosages, the company ensures quality control and supply chain efficiency across its diverse product portfolio.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于公司控股股东及共同实际控制人部分股份质押的公告 | 2026-05-21 | Chinese | |
| 2025年年度股东会决议公告 | 2026-05-20 | Chinese | |
| 关于举行2025年度业绩说明会的公告 | 2026-05-11 | Chinese | |
| 2025年年度审计报告 | 2026-04-27 | Chinese | |
| 2026年度董事、高级管理人员薪酬方案 | 2026-04-27 | Chinese | |
| 关于2025年度拟不进行利润分配的公告 | 2026-04-27 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46757958 | 关于公司控股股东及共同实际控制人部分股份质押的公告 | 2026-05-21 | Chinese | ||
| 46702838 | 2025年年度股东会决议公告 | 2026-05-20 | Chinese | ||
| 45017804 | 关于举行2025年度业绩说明会的公告 | 2026-05-11 | Chinese | ||
| 37546854 | 2025年年度审计报告 | 2026-04-27 | Chinese | ||
| 37546808 | 2026年度董事、高级管理人员薪酬方案 | 2026-04-27 | Chinese | ||
| 37546802 | 关于2025年度拟不进行利润分配的公告 | 2026-04-27 | Chinese | ||
| 37546793 | 2025年年度报告 | 2026-04-27 | Chinese | ||
| 37546759 | 2025年年度报告摘要 | 2026-04-27 | Chinese | ||
| 37546753 | 2025年度独立董事述职报告(胡正喜) | 2026-04-27 | Chinese | ||
| 37546748 | 第六届董事会第三次会议决议公告 | 2026-04-27 | Chinese | ||
| 37546738 | 关于获得盐酸去甲乌药碱化学原料药上市申请批准通知书的公告 | 2026-04-21 | Chinese | ||
| 37546732 | 关于公司取得食品生产许可证的公告 | 2026-04-10 | Chinese | ||
| 37546731 | 关于股东权益变动触及1%整数倍的提示性公告 | 2026-04-08 | Chinese | ||
| 37546729 | 股票交易异常波动公告 | 2026-04-08 | Chinese | ||
| 37546727 | 关于持股5%以上股东及部分董事、高级管理人员减持计划实施完成的公告 | 2026-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Zhuhai Rundu Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54917/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54917 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54917 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54917 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54917}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zhuhai Rundu Pharmaceutical Co., Ltd. (id: 54917)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.